Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Open-label, Controlled, Randomized Trial of Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)

NCT06365502 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT06365502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06365502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Open-label, Controlled, Randomized Trial of Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
April 16, 2024
Completion date
December 31, 2030
Enrollment
1,860 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs)